Lexeo Therapeutics (LXEO) Change in Cash (2022 - 2026)
Lexeo Therapeutics (LXEO) posted Change in Cash of $8.8 million for Q1 2026, down 60.15% sequentially from $22.0 million in Q4 2025, and up 243.62% YoY from $2.6 million in Q1 2025.
Lexeo Therapeutics (LXEO) Change in Cash (2022 - 2026) Analysis & Trends
Lexeo Therapeutics has reported Change in Cash for 5 years, with the latest figure at $8.8 million in Q1 2026.
- Quarterly Change in Cash rose 243.62% year-over-year to $8.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $42.9 million (up 125.79% YoY) and the FY2025 annual result came in at $28.0 million, up 132.37% from the prior year.
- Change in Cash eased to $8.8 million in Q1 2026 per LXEO's latest filing, from $22.0 million in the prior quarter.
- Over five years, Change in Cash peaked at $86.0 million in Q4 2023 and troughed at -$122.0 million in Q4 2024.
- A 5-year average of -$1.6 million and a median of -$8.1 million in 2023 frame the typical range for Change in Cash.
- The sharpest annual moves came in 2023 and 2024: Change in Cash soared 611.58% in 2023, then sank 241.84% in 2024.
- Over 5 years, Change in Cash stood at -$16.8 million in 2022, then jumped by 611.58% to $86.0 million in 2023, then tumbled by 241.84% to -$122.0 million in 2024, then jumped by 118.04% to $22.0 million in 2025, then sank by 60.15% to $8.8 million in 2026.
- According to Business Quant data, Change in Cash over the past three periods registered $8.8 million, $22.0 million, and $5.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 374.50 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 427.25 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.97 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 225.59 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.94 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -37.42 Mn |
| 10 | Lexeo Therapeutics | 397.10 Mn | 397.10 Mn | - | 21.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 21.07 Mn |
| Mar 31, 2026 | 8.77 Mn |
| Dec 31, 2025 | 22.00 Mn |
| Sep 30, 2025 | 5.52 Mn |
| Jun 30, 2025 | 6.57 Mn |
| Mar 31, 2025 | -6.11 Mn |
| Dec 31, 2024 | -122.01 Mn |
| Sep 30, 2024 | -17.96 Mn |
| Jun 30, 2024 | -20.08 Mn |
| Mar 31, 2024 | 73.59 Mn |
| Dec 31, 2023 | 86.02 Mn |
| Sep 30, 2023 | -10.09 Mn |
| Jun 30, 2023 | -13.33 Mn |
| Mar 31, 2023 | -18.47 Mn |
| Dec 31, 2022 | -16.81 Mn |